iSpecimen ( NASDAQ:ISPC – Get Rating ) is one of 44 public companies in the 'Commercial physical research' industry, but how does it compare to its competitors? We will compare iSpecimen to related businesses based on the strength of its analyst recommendations, valuation, dividends, earnings, risk, profitability and institutional ownership. Insider & Institutional Ownership 11.6% of iSpecimen shares are owned by institutional investors. Comparatively, 52.5% of shares of all 'Commercial physical research' companies are owned by institutional investors.

https://www.dailypolitical.com/2023/04/08/ispecimen-ispc-its-competitors-financial-comparison.html

#dailypolitical